CTDH - Very nice growth. Great share structure and the ceo does a monthly video to let shareholders know what is going on. They just recently refinced their dept with great terms and the ceo has also indicated they are going to hire an IR dept to increase investor awareness. If they can continue on their current growth trajectory this could be one huge play.
This is taken from the most recent 10Q.
"Total product sales for the three month period ended June 30, 2013 increased 378% to $709,000 compared to $148,000 for the same period in 2012. Total product sales for the six month period ended June 30, 2013 increased 142% to $1,292,000 compared to $533,000 for the same period in 2012. This increase is due primarily to the distribution of our Trappsol® Cyclo ™ for treatment of Brazilian children with NPC. Sales of our new liquid form of Trappsol® Cyclo™ were $563,000 for the six months ended June 30, 2013. This product was first available for sale in the fourth quarter of 2012."
Cyclo Therapeutics, Inc. (CTDHD) Stock Research Links